Dentsply Sirona Stock Sinks On Missed Expectations, Lowered 2025 Guidance; CEO Unveils Return-To-Growth Plan
1. XRAY reported adjusted earnings of 37 cents, below last year's 50 cents. 2. Sales declined 5% year-over-year, totaling $904 million, slightly above expectations. 3. CFO Matt Garth departed; interim CFO Leslie Varon has been appointed. 4. Fiscal 2025 earnings guidance lowered to $1.60 per share, below consensus. 5. Management's Return-to-Growth strategy aims for sustained growth over 24 months.